Table 1. Patient characteristics at the... | American Society of Hematology

Table 1.

Patient characteristics at the time of the first ponatinib CSF quantification and outcomes

Patient number	Sex	Age, y	Prior HSCT	Prior RT	First line or relapse	History of CNS disease	Active CNS disease	Active systemic disease	Outcome
1	Female	31	No	TBI	Relapse	No	No	No	CR
2	Female	57	No	TBI	Relapse	No	No	Yes	CR
3	Female	72	No	No	Relapse	Yes	Yes	Yes	CR
4	Male	61	No	No	First line	No	No	No	CR
5	Male	49	No	No	First line	Yes	No	Yes	Systemic relapse
6	Male	81	No	No	Relapse	Yes	No	Yes	CNS relapse
7	Male	58	Yes	No	First line	No	No	Yes	CR
8	Male	23	Yes	TBI	Relapse	Yes	No	No	CR
9	Male	40	No	No	First line	No	No	Yes	CR
10	Male	31	Yes	TBI	Relapse	Yes	Yes	Yes	CNS relapse
11	Female	62	No	No	First line	No	No	No	CR
12	Female	56	No	No	First line	Yes	No	Yes	CR
13	Male	23	Yes	TBI	Relapse	Yes	No	Yes	CR
14	Female	53	No	No	First line	No	No	No	Systemic relapse
15	Female	59	No	No	First line	Yes	Yes	Yes	CR
16	Female	68	No	No	First line	Yes	No	Yes	CR

Patient number	Sex	Age, y	Prior HSCT	Prior RT	First line or relapse	History of CNS disease	Active CNS disease	Active systemic disease	Outcome
1	Female	31	No	TBI	Relapse	No	No	No	CR
2	Female	57	No	TBI	Relapse	No	No	Yes	CR
3	Female	72	No	No	Relapse	Yes	Yes	Yes	CR
4	Male	61	No	No	First line	No	No	No	CR
5	Male	49	No	No	First line	Yes	No	Yes	Systemic relapse
6	Male	81	No	No	Relapse	Yes	No	Yes	CNS relapse
7	Male	58	Yes	No	First line	No	No	Yes	CR
8	Male	23	Yes	TBI	Relapse	Yes	No	No	CR
9	Male	40	No	No	First line	No	No	Yes	CR
10	Male	31	Yes	TBI	Relapse	Yes	Yes	Yes	CNS relapse
11	Female	62	No	No	First line	No	No	No	CR
12	Female	56	No	No	First line	Yes	No	Yes	CR
13	Male	23	Yes	TBI	Relapse	Yes	No	Yes	CR
14	Female	53	No	No	First line	No	No	No	Systemic relapse
15	Female	59	No	No	First line	Yes	Yes	Yes	CR
16	Female	68	No	No	First line	Yes	No	Yes	CR

CR, complete remission; HSCT, hematopoietic stem cell transplantation; RT, radiotherapy; TBI, total body irradiation.